Expert Interviews

Christopher Bunick, MD, shares highlights of his session from the 2022 Fall Clinical conference in Las Vegas, Nevada, October 20-23.

Mark G. Lebwohl, MD, and Joseph F. Merola, MD, MMSc, provide impressions to the case and take-home messages for dermatologists and rheumatologists treating psoriasis.

Mark G. Lebwohl, MD, presents a case of a 45-year-old Caucasian male diagnosed with psoriasis.

In this week’s Pointers with Dr Portela, the 208SkinDoc discusses holistic medicine vs. western medicine for eczema treatment.

Drs Mark G. Lebwohl and Joseph F. Merola discuss the use of biosimilars in psoriasis and how biosimilars will change the treatment landscape.

Mark G. Lebwohl, MD, and Joseph F. Merola, MD, MMSc, provide insight on when it is appropriate to switch from one biologic to another for a patient with psoriasis.

The legacy of the late Vic Narurkar, MD, and his commitment to aesthetics was honored at the 2022 Annual ASDS Meeting.

At the 2022 Annual ASDS Meeting, Mona Gohara, MD, highlights the importance of diversity, equity, and inclusion in the field of dermatology.

Sherrif Ibrahim, MD, PhD, provides key pearls from his co-directed session at the 2022 Annual ASDS Meeting, “Defining ‘High-Risk’ for Squamous Cell Carcinoma: Implications for Treatment Paradigms.”

Mona Gohara, MD, gives an overview and 3 highlights from her presentation, “How to Build and Design a Dermatologic Practice,” at the 2022 ASDS Annual Meeting.

Patricia Farris, MD, dermatologist from Metairie, Louisiana, discusses key pearls from her presentation at the American Society for Dermatologic Surgery (ASDS) Meeting.

Peter Lio, MD, talks about the difficulties and strategies used when treating patients with this common skin disorder.

Patricia Farris, MD, dermatologist from Metairie, Louisiana, discusses why the American Society for Dermatologic Surgery (ASDS) Annual Meeting is one of her favorite conferences to attend.

Expert dermatologists discuss different anti-TNF molecules and the impact of having these types of molecules on psoriasis and psoriatic arthritis care.

Mark G. Lebwohl, MD, and Joseph F. Merola, MD, MMSc, discuss different head-to-head studies in psoriasis.

Sherrif F. Ibrahim, MD, PhD, and Vishal Patel, MD, FAAD, FACMS, provide initial impressions of the case and discuss the use of immune checkpoint inhibitors.

Sherrif F. Ibrahim, MD, PhD, presents the case of a 49-year-old White woman with neglected large basal cell carcinoma.

Expert dermatologists discuss future directions for the management of basal cell carcinoma.

Sanofi and Regeneron’s dupliumab will provide relief to patients with extreme itch and skin lesions.

Mark G. Lebwohl, MD, and Joseph F. Merola, MD, MMSc, provide tips to overcome diagnostic delay in psoriasis.

Expert dermatologists discuss challenges in diagnosing a patient with PsA.

In this week’s Pointers with Dr Portela, the 208SkinDoc discusses common skin conditions related to polycystic ovary syndrome.

Sherrif F. Ibrahim, MD, PhD, and Vishal Patel, MD, FAAD, FACMS, discuss the impact of immune checkpoint inhibitors used in BCC.

Experts in dermatology discuss the treatment landscape for BCC.

Roflumilast cream adds a much-needed element of simplicity for psoriasis patients and their dermatologists.

In this week’s Pointers with Dr Portela, the 208SkinDoc reviews a video of laser tattoo removal.

Drs Mark G. Lebwohl and Joseph F. Merola discuss how patient presentation differs in patients with PsO and PsA.

Mark G. Lebwohl, MD, and Joseph F. Merola, MD, MMSc, discuss updates in the pathogenesis of PsA and PsO.

Drs Roy M. Fleischmann and Joel M. Gelfand discuss addressing patient concerns with biosimilars and provide take-home messages to clinicians utilizing biosimilars.

Roy M. Fleischmann, MD, and Joel M. Gelfand, MD, MSCE, FAAD, address the importance of clinician confidence in biosimilars.